Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 2003

View Archived Issues

Spotlight on F-13640, a 5-HT1A receptor agonist for the treatment of neuropathic pain

NW-1029 inhibits Na+ currents in rat sensory neurons

NO-releasing paracetamol derivative NCX-701 reduces pain-related behavior in nerve-injured rats

Antihyperalgesic effects of cizolirtine in diabetic rats via adenosine A1 and CCK2 receptors

PJ-34, a PARP inhibitor, reverses early diabetic neuropathy in rats

New antitumor, antibacterial and antifungal agents from Penicillium sp.

Pfizer presents novel PDE4 inhibitors and their use

Novel cathepsin K inhibitors under study at Aventis

Neurocrine patent covers series of pyrrole-based melanocortin receptor modulators

KCNQ potassium channel openers identified by ICAgen researchers

GSK patent describes new vanilloid VR1 antagonists, their preparation and use

Serostim E.U. appeal results in second negative opinion

Incyte and Pharmasset enter Reverset licensing agreement

New phase II trial evaluates MDX-010 for metastatic breast cancer

Second phase III trial of SPI-0211 for constipation completes enrollment

Taisho ends anti-CD23 collaboration

Long-term phase I/II data support use of I2S for Hunter's syndrome

Teva submits rasagiline NDA for Parkinson's disease

Completion of phase I Aurexis study

SBIR grant supports StemCells' spinal cord injury work

New siRNA agents demonstrate inhibition of SARS virus

Pregabalin safe and effective in postherpetic neuralgia and fibromyalgia syndrome

Everolimus alleviates cardiac vasculopathy after heart transplant

Discovery and SAR of a series of sulfonamides as JNK inhibitors reported by Serono

J&J presents new series of histamine H3 antagonists with biological activity

Boehringer Ingelheim presents data on new HCV NS5B RNA-dependent RNA polymerase inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...